📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Immunis AI

1.1 - Company Overview

Immunis AI Logo

Immunis AI

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of non-invasive, blood-based Active Surveillance Tests for active surveillance and early detection of diseases, initially validated for prostate cancer with future applications in other urological cancers.

Products and services

  • Active Surveillance Tests: Non-invasive blood-based assays engineered for active surveillance and early detection, initially validated for prostate cancer with future applications in other urological cancers

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Immunis AI

Five Prime Therapeutics Logo

Five Prime Therapeutics

HQ: United States Website
  • Description: Provider of cancer treatment biotechnology, discovering and developing novel therapeutic proteins and antibodies by systematically screening all relevant human proteins to find the best for each clinical indication, enabled by its ProScreen Engine for rapid production and screening.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Five Prime Therapeutics company profile →
Ceptaris Logo

Ceptaris

HQ: United States Website
  • Description: Provider of a proprietary gel formulation of mechlorethamine hydrochloride under development for the treatment of early-stage (stages I–IIA) mycosis fungoides, a type of cutaneous T-cell lymphoma (CTCL); if approved, it would be the first topical treatment for this indication.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ceptaris company profile →
Admune Therapeutics Logo

Admune Therapeutics

HQ: United States Website
  • Description: Provider of development and delivery of cytokine therapy drugs for cancer as a clinical-stage biotech company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Admune Therapeutics company profile →
Chinook Therapeutics Logo

Chinook Therapeutics

HQ: Canada Website
  • Description: Provider of precision medicines for kidney diseases, leveraging novel translational platforms and patient stratification tools. Pipeline includes Atrasentan, a selective ETA receptor antagonist in phase 3 for IgA nephropathy and phase 2 for other proteinuric glomerular diseases; Zigakibart (BION-1301), an anti-APRIL monoclonal antibody in phase 3 and phase 1/2 for IgA nephropathy; and CHK-336, an oral LDHA inhibitor in phase 1 for primary and idiopathic hyperoxaluria.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chinook Therapeutics company profile →
858 Therapeutics Logo

858 Therapeutics

HQ: United States Website
  • Description: Provider of small molecule drug development targeting oncology and immunology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 858 Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Immunis AI

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Immunis AI

2.2 - Growth funds investing in similar companies to Immunis AI

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Immunis AI

4.2 - Public trading comparable groups for Immunis AI

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Immunis AI

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Immunis AI

What does Immunis AI do?

Immunis AI is a provider of non-invasive, blood-based Active Surveillance Tests for active surveillance and early detection of diseases, initially validated for prostate cancer with future applications in other urological cancers.

Who are Immunis AI's competitors?

Immunis AI's competitors and similar companies include Five Prime Therapeutics, Ceptaris, Admune Therapeutics, Chinook Therapeutics, and 858 Therapeutics.

Where is Immunis AI headquartered?

Immunis AI is headquartered in United States.

How many employees does Immunis AI have?

Immunis AI has 1,000 employees 🔒.

When was Immunis AI founded?

Immunis AI was founded in 2010 🔒.

What sector and industry vertical is Immunis AI in?

Immunis AI is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Immunis AI

Who are the top strategic acquirers in Immunis AI's sector and industry

Top strategic M&A buyers and acquirers in Immunis AI's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Immunis AI?

Top strategic M&A buyers groups and sectors for Immunis AI include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Immunis AI's sector and industry vertical

Which are the top PE firms investing in Immunis AI's sector and industry vertical?

Top PE firms investing in Immunis AI's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Immunis AI's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Immunis AI's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Immunis AI's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Immunis AI include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Immunis AI's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Immunis AI?

The key public trading comparables and valuation benchmarks for Immunis AI include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Immunis AI for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Immunis AI with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Immunis AI's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Immunis AI with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Immunis AI's' sector and industry vertical?

Access recent funding rounds and capital raises in Immunis AI's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Immunis AI